New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
08:32 EDTSPPI, ANACAnacor appoints Paul L. Berns as CEO, effective immediately
Berns succeeds David P. Perry who has served as Anacorís (ANAC) President and CEO since 2002. Berns has over 20 years of industry experience as an executive in biotechnology and pharmaceutical companies. He most recently served as the President and Chief Executive Officer of Allos Therapeutics prior to its acquisition by Spectrum Pharmaceuticals (SPPI) in 2012.
News For ANAC;SPPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:02 EDTANACOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:27 EDTANACAnacor initiated with a Neutral at Goldman
Goldman Sachs views Anacor Pharmaceuticals as an attractive dermatology name, but finds the stock fairly valued at current levels. The firm started shares with a Neutral rating and $36 price target.
December 8, 2014
07:29 EDTANACUBS to hold investor trip
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use